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Prevention of long-term 
memory loss after retrieval by an 
endogenous CaMKII inhibitor
Fabio Antonio Vigil, Keiko Mizuno, Walter Lucchesi, Victoria Valls-Comamala & Karl Peter 
Giese
CaMK2N1 and CaMK2N2 are endogenous inhibitors of calcium/calmodulin-dependent protein kinase 
II (CaMKII), a key synaptic signaling molecule for learning and memory. Here, we investigated the 
learning and memory function of CaMK2N1 by knocking-down its expression in dorsal hippocampus of 
mice. We found that reduced CaMK2N1 expression does not affect contextual fear long-term memory 
(LTM) formation. However, we show that it impairs maintenance of established LTM, but only if retrieval 
occurs. CaMK2N1 knockdown prevents a decrease of threonine-286 (T286) autophosphorylation of 
αCaMKII and increases GluA1 levels in hippocampal synapses after retrieval of contextual fear LTM. 
CaMK2N1 knockdown can also increase CaMK2N2 expression, but we show that such increased 
expression does not affect LTM after retrieval. We also found that substantial overexpression of 
CaMK2N2 in dorsal hippocampus impairs LTM formation, but not LTM maintenance, suggesting 
that CaMKII activity is not required for LTM storage. Taken together, we propose a specific function 
for CaMK2N1; enabling LTM maintenance after retrieval by inhibiting T286 autophosphorylation of 
αCaMKII.
CaMKII is a key synaptic signaling molecule that enables learning and memory processes. In particular, the 
autophosphorylation at T286 of αCaMKII, the major CaMKII isoform in forebrain, is fundamentally impor-
tant for LTM formation1–4. This autophosphorylation not only prolongs αCaMKII activity, it also regulates 
interaction with various proteins resulting in different downstream effects5. For example, a phosphomimetic 
mutation of the T286 autophosphorylation site increases the immobilization of α-amino-3-hydroxy-5-methyl
-4-isoxazolepropionic acid (AMPA) receptors containing the GluA1 subunit within the synapse6. The regulation 
of AMPA receptor localization by CaMKII has been hypothesized to be an important molecular basis for LTM 
maintenance7. However, a role for CaMKII in LTM maintenance is still a matter of debate. Irvine, et al.2 reported 
that knock-in mutants lacking the T286 autophosphorylation of αCaMKII form and maintain LTM after inten-
sive training. Additionally, Buard, et al.4 observed that inhibition of CaMKII, by the CaMK2N1-derived peptide 
tatCN21, impairs contextual fear LTM formation with no effect on LTM maintenance.
While the biochemistry underlying T286 autophosphorylation of αCaMKII is well known8, the regulation of 
this autophosphorylation is not sufficiently understood. We hypothesized that the endogenous CaMKII inhibitor 
proteins, CaMK2N1 and CaMK2N29, 10, are important regulators of memory-induced changes in T286 auto-
phosphorylation, as their expression levels are elevated during consolidation of contextual fear memory11, 12. 
CaMK2N1 mRNA levels are increased in the hippocampus after contextual fear conditioning (CFC)11. CFC also 
increases amygdalar CaMK2N2 mRNA expression while hippocampal levels were changed by exposure to a novel 
context12. CaMK2N1 is a 78 amino acid protein with high levels of expression in the frontal cortex, hippocam-
pus and inferior colliculus. CaMK2N2 has 79 amino acids, and is expressed in testis and brain, where it has 
higher expression in cerebellum and hindbrain. Both inhibitors block CaMKII activity. However, CaMK2N2 but 
not CaMK2N1 requires constant presence of calcium/calmodulin to bind to CaMKII10. The inhibitory effects 
of both endogenous CaMKII inhibitors seem to be related to the binding of these peptides to a hydrophobic 
region of the kinase domain of CaMKII, known as the T-site, which blocks access of the substrate to the kinase 
domain but does not directly block the T286 site. The endogenous inhibitors of CaMKII are also thought to affect 
how CaMKII interacts with other proteins, regulate CaMKII autophosphorylation at sites other than T286, and 
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decrease calcium/calmodulin dissociation from CaMKII13. Despite their regulation during memory consolida-
tion, the importance of CaMK2N1 and CaMKN2 for learning and memory is still unknown. It also remains to be 
determined if CaMK2N1 and CaKM2N2 have different functions. Here, we have studied the role of CaMK2N1 
and, surprisingly, show that this endogenous CaMKII inhibitor is required for maintenance of established LTM 
after retrieval.
Results
CaMK2N1 is not necessary for contextual fear LTM formation, maintenance and retrieval. In 
order to determine the function of CaMK2N1 in LTM formation and maintenance we prepared an shRNA-ex-
pressing recombinant adeno-associated virus (rAAV) to knockdown CaMK2N1 expression. This rAAV and a 
shRNA-control rAAV were injected into dorsal hippocampi of mice and LTM formation and maintenance were 
tested in the CFC paradigm. Injection of rAAV in the hippocampi of mice and efficient infection of neurons 
was confirmed by visualization of ZsGreen reporter protein expression (see Supplementary Fig. S1). The rAAV 
expressing CaMK2N1 shRNA reduced CaMK2N1 mRNA expression by about 80% in dorsal hippocampus, but 
did not alter expression levels in ventral hippocampus (Supplementary Fig. S2). For this reason, only dorsal hip-
pocampus samples were used in all following experiments.
We proceeded to test whether knockdown of CaMK2N1 expression affects contextual fear LTM formation, 
since CaMK2N1 expression is upregulated in hippocampus during consolidation of this type of memory11. Two 
weeks after transfection with the rAAVs the mice were conditioned and tested for contextual fear LTM after 4 
days (Fig. 1a). This experiment was designed to test if the training-induced expression of CaMK2N111 is neces-
sary for learning, consolidation and/or memory retrieval. One-way analysis of variance (ANOVA) of the freezing 
scores, which are indicative of fear memory, revealed that contextual fear LTM did not differ between the groups 
(F1,38 = 1.0; P = 0.32). This finding shows that reducing CaMK2N1 expression in dorsal hippocampus does not 
impair contextual fear LTM formation, maintenance and retrieval. The efficient knockdown of CaMK2N1 expres-
sion in the dorsal hippocampi of the animals was confirmed by quantitative real-time polymerase chain reaction 
(RT-qPCR) (F1,38 = 66.1; P < 0.001) (Fig. 1b). Specificity of rAVV treatment was confirmed by quantification of 
Figure 1. CaMK2N1 shRNA expression in dorsal hippocampus does not affect contextual fear LTM formation, 
storage and retrieval. (a) Dorsal hippocampi of mice were transfected with rAAV expressing either control 
shRNA (n = 19) or CaMK2N1 shRNA (n = 20). Contextual fear LTM was determined 4 days after conditioning. 
(b) Quantitative analysis of CaMK2N1 mRNA expression in dorsal hippocampi of animals from (a) (shControl, 
n = 19; shCaMK2N1, n = 20). (c) Quantitative analysis of CaMK2N2 mRNA expression in dorsal hippocampi of 
animals from (a). (shControl, n = 19; shCaMK2N1, n = 20). (d) Freezing scores obtained during conditioning 
of the animals from (a). Training session is divided here between before and after the shock. No animal in the 
shCaMK2N1 group presented any freezing before shock, resulting in a mean freezing of 0 and 0 of S.E.M. Two-
way ANOVA test with repeated measures revealed a significant effect of the foot-shock (F1,37 = 32.0; P < 0.001), 
with no effect of rAAV treatment (F1,37 = 1.7; P = 0.120) or interaction between these two factors (F1,37 = 0.0; 
P = 0.84). SNK post-hoc comparisons revealed a significant increase in freezing scores between before and after 
the shock for both shControl (n = 19) (q = 5.7; P < 0.001) and shCaMK2N1 (n = 20) (q = 5.5; P < 0.001) groups. 
No significant difference was obtained when comparing animals from shControl and shCaMK2N1 within 
before (q = 1.0; P = 0.44) or after (q = 1.4; P = 0.29) foot-shock. Mean and S.E.M.; ***P < 0.001.
www.nature.com/scientificreports/
3Scientific RepoRts | 7: 4040  | DOI:10.1038/s41598-017-04355-8
CaMK2N2 mRNA levels (F1,38 = 0.08; P = 0.77) (Fig. 1c). Freezing scores during CFC training session confirmed 
that freezing behavior was present only after pairing of shock and context and that shCaMK2N1 treatment did 
not affect shock reactivity (Fig. 1d).
Upregulation of CaMK2N1 and CaMK2N2 mRNA after contextual fear LTM retrieval. Previously, 
we showed that CFC transiently increases the expression levels of CaMK2N1 and CaMK2N211, 12. However, the 
impact of contextual fear LTM retrieval on the levels of CaMK2N1 and CaMK2N2 mRNA was unknown. Thus, 
we studied whether hippocampal CaMK2N1 and CaMK2N2 mRNA expression differed in mice with retrieval 
of contextual fear LTM versus mice without retrieval (Fig. 2a). It is important to note that different from our pre-
vious publications11, 12 these experiments were designed to look for retrieval-induced changes in CaMK2N1 and 
CaMK2N2 mRNA levels. Using three foot shocks, the comparison revealed a significant increase in CaMK2N1 
mRNA levels (F1,9 = 21.8; P < 0.01), by about 70% in the group subjected to LTM retrieval (Fig. 2a). This increase 
is of comparable magnitude to the ~50% increase in CaMK2N1 mRNA levels observed after CFC training, 
reported in previous publication by our group11. A retrieval-induced upregulation was not found for CaMK2N2 
in these conditions (F1,9 = 0.04; P = 0.84) (Fig. 2b). On the other hand, conditioning mice with more shocks 
resulted in a retrieval-induced increase in CaMK2N2 mRNA levels (F1,11 = 5.4; P = 0.04) (Fig. 2d) with no effect 
on CaMK2N1 mRNA (F1,11 = 1.8; P = 0.20) (Fig. 2c). Therefore, CaMK2N1 may play a role in the maintenance 
of a weaker LTM after retrieval, while CaMK2N2 might be required for maintaining stronger LTM after retrieval.
CaMK2N1 knockdown leads to impairment of contextual fear LTM after retrieval. Since 
CaMK2N1 expression is upregulated after retrieval of relatively weak LTM, we tested whether knock-
down of CaMK2N1 expression impairs contextual fear LTM after retrieval of one-trial contextual fear LTM 
(Fig. 3a). Considering that the experiments presented in Fig. 2 revealed that a low number of shocks favors 
retrieval-induced expression of CaMK2N1, and our aim was to investigate the function of this specific CaMKII 
Figure 2. Effect of contextual fear memory retrieval on CaMK2N1 and CaMK2N2 dorsal hippocampi 
mRNA levels. (a) Animals (n = 10) were conditioned with 3 foot shocks (0.7 mA, 2 s). Half of the conditioned 
animals retrieved contextual fear LTM for 5 minutes 24 hours after conditioning (TR + TE). All animals were 
sacrificed 24.5 h after conditioning and mRNA expression in dorsal hippocampi was studied using RT-qPCR 
analysis. Retrieval of contextual fear LTM significantly upregulated CaMK2N1 expression. (b) CaMK2N2 
mRNA levels were not altered by reactivation of contextual fear LTM. (c) A different cohort of animals 
(n = 12) was conditioned with 5 foot shocks (0.7 mA, 2 s) and, as in panel (a), half of the animals retrieved 
contextual fear LTM. CaMK2N1 expression did not change by retireval of this stronger contextual fear LTM. 
(d) However, CaMK2N2 mRNA levels were significantly increased by LTM retrieval. Hence, the intensity 
of the unconditioned stimulus influences the effect that memory retrieval has on the expression of the two 
endogenous CaMKII inhibitors. Mean and S.E.M.; *P < 0.05; **P < 0.01.
www.nature.com/scientificreports/
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endogenous inhibitor, we used only one foot-shock in the experiments shown in Fig. 3. After transfection of 
dorsal hippocampi with control or CaMK2N1 shRNA rAAV, mice were conditioned and tested for contextual 
fear LTM after one day followed by a second LTM test 4 days after conditioning. Two-way ANOVA with repeated 
measures showed a significant effect of memory tests (F1,24 = 9.0; P < 0.01) and a significant interaction between 
the memory tests and rAVV treatment (F1,24 = 8.1; P < 0.01). Student–Newman–Keuls (SNK) post-hoc compar-
isons revealed that CaMK2N1 shRNA expression significantly impaired contextual fear LTM only in the second 
LTM test in comparison with the control group (q = 3.4; P < 0.05). Further, there was a significant difference 
between first and second LTM test only within the mice expressing CaMK2N1 shRNA (q = 5.4; P < 0.001) 
(Fig. 3a). The same behavioral phenotype was observed in an independent replica experiment (Supplementary 
Fig. S3). Finally, it was confirmed that CaMK2N1 mRNA expression was substantially reduced in the behaviorally 
tested mice (F1,25 = 17.7; P < 0.001) (Fig. 3b). We found that in CaMK2N1 shRNA expressing mice CaMK2N2 
mRNA expression was significantly elevated (F1,25 = 13.3; P < 0.01) (Fig. 3c). A correlation analysis suggests that 
the increased CaMK2N2 expression might be a compensation for the down-regulation of CaMK2N1 expres-
sion in these mice (Supplementary Fig. S4). That being the case, the compensation was not enough to avoid the 
retrieval-induced memory impairment after CaMK2N1 knockdown. Effects of this CaMK2N2 increase will be 
addressed later in this article.
CaMK2N1 knockdown affects synaptic αCaMKII T286 autophosphorylation and GluA1 lev-
els, after LTM retrieval. To study the impact of CaMK2N1 knockdown on CaMKII function we analyzed 
αCaMKII autophosphorylation at T286 in synaptosomes from dorsal hippocampi. T286 autophosphorylation 
levels were compared between mice that underwent CFC (TR group) and mice that underwent CFC and LTM 
retrieval (TR + TE group) (Fig. 3d). Two-way ANOVA analysis of T286 autophosphorylation levels showed a 
Figure 3. CaMK2N1 expression is necessary for contextual fear LTM maintenance after retrieval and regulates 
synaptic CaMKII T286 autophosphorylation and GluA1 levels. (a) Dorsal hippocampi of mice were transfected 
with rAAV expressing either control shRNA (n = 15) or CaMK2N1 shRNA (n = 11). Contextual fear LTM was 
determined one day after conditioning and for a second time 4 days after conditioning. CaMK2N1 shRNA 
expression in hippocampus impaired contextual fear LTM after retrieval. (b) All mice in (a) had a significant 
knockdown of CaMK2N1 mRNA expression in hippocampus. (c) In this cohort of mice, knockdown of 
CaMK2N1 caused a significant increase in CaMK2N2 mRNA expression. (d) To understand the retrieval-
induced effects of CaMK2N1 knockdown mice were treated with shCaMK2N1 rAAV treatment and trained and 
tested (TR + TE) in the CFC paradigm or just trained (TR). Dorsal hippocampi samples were collected 2 hours 
after retrieval of contextual fear LTM, and protein samples prepared for western blots. Retrieval of contextual 
fear LTM significantly decreased αCaMKII autophosphorylation at T286 in synaptosomes (shControl: TR, 
n = 7, TR + TE, n = 5). This decrease in T286 autophosphorylation was impaired by shCaMK2N1 expression 
(TR, n = 7; TR + TE, n = 7). (e) shCaMK2N1 expression did not impact on αCaMKII protein levels (shControl: 
TR, n = 7, TR + TE, n = 6; shCaMK2N1: TR, n = 7; TR + TE, n = 7) (see statistics on Supplementary Table S4). 
(f) Quantification of GluA1 synaptosomal levels of the same cohort of animals revealed a retrieval-dependent 
increase due to CaMK2N1 knockdown (shControl: TR, n = 6, TR + TE, n = 5; shCaMK2N1: TR, n = 7; 
TR + TE, n = 7). Example immunoblotting staining for these proteins can be found below each graph and in 
Supplementary Fig. S7. Mean and S.E.M.; *P < 0.05; **P < 0.01; ***P < 0.001.
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significant effect of shCaMK2N1 expression (F1,26 = 6.6; P < 0.05) (Fig. 3d). Post-hoc comparisons revealed a sig-
nificant decrease in T286 autophosphorylation between TR + TE and TR mice, only for the control treatment 
(q = 3.1; P < 0.05), and not for the shCaMK2N1 treatment (q = 0.6; P = 0.67). A significant difference in T286 
autophosphorylation levels was also observed between control and shCaMK2N1 treatment only for TR + TE 
mice (q = 3.7; P < 0.05), but not within TR animals (q = 1.2; P = 0.382). Thus, LTM retrieval reduced T286 auto-
phosphorylation levels in control mice, but not in CaMK2N1 knockdown mice. This retrieval-induce change 
in T286 autophosphorylation may occur at synapses only, as it was not detected in the cytoplasmic fraction 
(Supplementary Fig. S5). Total αCaMKII protein levels were not affected by CaMK2N1 knockdown (Fig. 3e and 
Supplementary Fig. S6).
To look for downstream effects of CaMK2N1 knockdown and the observed increase in T286 autophospho-
rylation, GluA1 levels were quantified in the same synaptosomal samples (Fig. 3f). Two-way ANOVA revealed a 
significant effect of CaMK2N1 knockdown in GluA1 levels (F1,25 = 4.9; P = 0.03). Post-hoc comparisons showed a 
significant increase in GluA1 levels of shCaMK2N1 animals compared with shControl only when animals under-
went memory retrieval (q = 3.2; P = 0.03), but not when they were only trained (q = 1.0; P = 0.44). There was no 
significant difference between TR and TR + TE animals when comparing within shControl (q = 1.7; P = 0.220) 
or shCaMK2N1 (q = 0.4; P = 0.757) animals.
Increased hippocampal CaMK2N2 expression impairs LTM formation but does not affect LTM 
maintenance after retrieval. Considering that the animals that presented a retrieval-induced LTM 
impairment after CaMK2N1 knockdown (Fig. 3a) also had an increase in CaMK2N2 expression (Fig. 3c), the 
LTM impairment observed could have been due to the increased CaMK2N2 expression. To study this possibility, 
we prepared a rAAV that overexpresses CaMK2N2 under control of the synapsin 1 promoter (see Supplementary 
Methods). After infection of dorsal hippocampi with control or CaMK2N2-expressing rAAVs, mice were condi-
tioned and tested for contextual fear LTM after one day followed by a second LTM test 4 days after conditioning 
(Fig. 4a). Analysis of the freezing scores using two-way ANOVA with repeated measures indicated that transfec-
tion with the CaMK2N2-expressing rAAV did not lead to an effect of treatment (F1,22 = 3.0; P = 0.09) and there 
was no significant interaction between treatment and the memory tests (F1,22 = 0.3; P = 0.59). mRNA expression 
analysis confirmed that the CaMK2N2-expressing rAAV significantly elevated CaMK2N2 expression by about 
~2.5 fold (F1,20 = 81.1; P < 0.001) (Fig. 4b), which is comparable to the ~1.5 fold increase observed as a com-
pensation after CaMK2N1 knockdown treatment (Fig. 3c). CaMK2N2 overexpression treatment did not alter 
CaMK2N1 expression (F1,19 = 3.2; P = 0.09) (Fig. 4c). Hence, the reduced CaMK2N1 expression directly caused 
the contextual LTM impairment after retrieval, not the compensatory increase in CaMK2N2 expression (Fig. 3a).
Using a 60x more concentrate version of the CaMK2N2-expressing rAAVs solution we obtained an ~80-fold 
increase in CaMK2N2 mRNA levels in dorsal hippocampus (Fig. 4e). We conditioned this cohort of animals and 
tested their LTM 24 hours and 4 days after conditioning (Fig. 4d). A two-way ANOVA with repeated measures 
revealed a significant effect of CaMK2N2 overexpression (F1,19 = 4.7; P = 0.04) and a significant effect of the mem-
ory tests (F1,19 = 10.3; P = 0.004), but no interaction between these factors (F1,19 = 0.01; P = 0.92). SNK post-hoc 
comparisons revealed a significant decrease of freezing behavior in CaMK2N2 overexpression animals, when 
compared with control group, in the 24-hour memory test (q = 2.9; P = 0.04), and a trend in the 4-day mem-
ory test (q = 2.8; P = 0.05). This result suggests that a high-level CaMK2N2 overexpression in the hippocampus 
impairs LTM formation. SNK planned comparisons also revealed a significant effect of the LTM tests within the 
control rAAV (q = 3.4; P = 0.02) and within the CaMK2N2 rAAV 60x group (q = 3.0; P = 0.04). Two hours after 
the last LTM test hippocampal samples were collected for RT-qPCR analysis. A significant increase in CaMK2N2 
mRNA levels (F1,20 = 48.6; P < 0.001) (Fig. 4e) were observed with no significant effect on CaMK2N1 mRNA 
expression (F1,20 = 3.1; P = 0.09) (Fig. 4f), thereby confirming the specificity and efficiency of the rAAV treatment.
To test for any effect of CaMK2N2 overexpression on contextual fear LTM maintenance the rAAV was injected 
24 hours after CFC and contextual fear LTM was tested 14 and 17 days after the infection (Fig. 4g). No effect of 
rAAV treatment on LTM was observed (F1,13 = 1.4; P = 0.25) under these conditions. There was a significant effect 
of the repeated LTM tests (F1,13 = 39.1; P < 0.001), but this effect presented no interaction with the rAAV treat-
ment (F1,13 = 0.04; P = 0.84). SNK planned comparisons also showed no significant effect of high- level CaMK2N2 
overexpression in the first (q = 1.6; P = 0.25) and second (q = 1.4; P = 0.32) LTM test. There was only a significant 
difference between the freezing scores on the first and second LTM test within the control rAAV group (q = 6.6; 
P < 0.001) and within the CaMK2N2 rAAV 60x group (q = 5.8; P = 0.001). Therefore, CaMK2N2 overexpression 
after training had no effect on LTM maintenance. RT-qPCR analysis confirmed substantial CaMK2N2 overex-
pression (F1,14 = 45.9; P < 0.001) (Fig. 4h) with no effect on CaMK2N1 expression (F1,14 = 0.5; P = 0.46) (Fig. 4i).
Discussion
Investigating the function of the endogenous CaMKII inhibitors in learning and memory, we found that 
CaMK2N1 is essential for LTM maintenance after retrieval. Thus, our finding suggests that prevention of LTM 
impairment after retrieval requires sophisticated fine-tuning of CaMKII activity. Consistently, previous trans-
genic mouse studies have shown that elevated CaMKII activity at the time of retrieval leads to LTM loss13. We 
observed a reduction of T286 autophosphorylation of αCaMKII within dorsal hippocampus after LTM retrieval 
and this process required CaMK2N1. The CaMK2N1-dependent regulation of T286 autophosphorylation was 
not predicted by earlier in vitro work with the inhibitory domain of CaMK2N1, CN21, and purified αCaMKII14, 
which reported that T286 autophosphorylation would only be “mildly affected” by CaMK2N1. This discrepancy 
with our findings is likely to be a result of the difference between studying the whole CaMK2N1 protein instead 
of a 21 amino acid fragment and/or in vivo versus in vitro studies. Since CaMK2N1 does not physically block the 
T286 site, as it binds to αCaMKII in a different area14, it is likely that CaMK2N1 regulates T286 phosphorylation 
by regulating αCaMKII kinase activity.
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We also found that CaMK2N1 knockdown results in a retrieval-induced increase in synaptic GluA1 levels. 
It is known that T286 autophosphorylation augments αCaMKII activity15, 16 and that the kinase phosphoryl-
ates the scaffold protein stargazin, trapping GluA1-containing AMPA receptors within the synapse6. Therefore, 
the impairment in retrieval-induced decrease of T286 autophosphorylation due to CaMK2N1 knockdown, 
could explain a retrieval-induced increase in synaptic GluA1 levels. Consistently, GluA1 levels in the synapse 
have been shown before to be decreased in the dorsal hippocampus of mice when contextual fear memory is 
retrieved 24 hours after conditioning17. In contrast, memory extinction increases GluA1 levels in different 
regions of the brain including the dorsal hippocampus18, 19. Extinction also requires the T286 autophosphoryla-
tion3. Additionally, forgetting of spatial working memory is associated with increased T286 autophosphorylation 
and GluA1 levels20. Hence, it is possible that the retrieval-induced increase in T286 autophosphorylation and 
GluA1 levels due to CaMK2N1 knockdown disrupted the normal chain of molecular events induced by mem-
ory retrieval, facilitating extinction or memory loss. Nonetheless, more studies are necessary to link directly the 
observed effects of CaMK2N1 knockdown on GluA1 levels to the effects on LTM maintenance.
Another possible explanation for the memory phenotype observed after CaMK2N1 knockdown is an impair-
ment in memory destabilization/reconsolidation process. Memory destabilization, part of the memory recon-
solidation hypothesis, has been shown to be necessary for memory maintenance after retrieval20. It is possible 
that the retrieval-induced decrease in αCaMKII T286 autophosphorylation and synaptosomal GluA1 levels 
observed in control animals is part of the destabilization of a memory. In this case, the retrieval-induced increase 
Figure 4. Overexpression of CaMK2N2 in dorsal hippocampi impairs memory formation but does not impair 
contextual fear LTM maintenance. (a) Dorsal hippocampi of mice were transfected with rAAV expressing either 
ZsGreen (n = 13) or CaMK2N2 (n = 11) under control of a synapsin 1 promoter. Contextual fear LTM was 
determined one day and 4 days after conditioning. No significant difference was observed. (b) Mice studied 
in (a) overexpressed CaMK2N2 mRNA in dorsal hippocampus (Control rAAV, n = 11; CaMK2N2 rAAV, 
n = 10). (c) Overexpression of CaMK2N2 mRNA did not alter CaMK2N1 mRNA levels (Control rAAV, n = 9; 
CaMK2N2 rAAV, n = 9). (d) Another cohort of animals was subjected to the same experimental design as in 
(a) with the exception that these animals were treated with a 60x more concentrated version of the CaMK2N2 
rAAV solution (1.07 × 1013 GC/ml). In these mice CaMK2N2 overexpression reduced freezing scores in the 
first memory test, indicating impaired memory formation (Control rAAV, n = 11; CaMK2N2 rAAV, n = 10). 
(e) RT-qPCR analysis confirms effective overexpression of CaMK2N2 in dorsal hippocampi of CaMK2N2 
rAAV 60x animals (n = 10) compared to Control rAAV (n = 11). (f) CaMK2N2 rAAV 60x treatment did not 
affect CaMK2N1 mRNA levels (Control rAAV, n = 11; CaMK2N2 rAAV, n = 10). (g) A final cohort of animals 
was first conditioned in the CFC paradigm and 24 hours later treated with the 60x CaMK2N2 rAAV solution. 
A period of 2 weeks was waited to allow the genetic information from the vector to be expressed, after which 
the fear memory of the context was tested twice. The two tests were apart from each other by 3 days, therefore 
they were executed 15 days and 18 days after CFC conditioning. No significant effect of 60x CaMK2N2 rAAV 
treatment was observed in the freezing behavior (Control rAAV, n = 8; CaMK2N2 rAAV, n = 7). (h) CaMK2N2 
mRNA levels were increased after 60x CaMK2N2 rAAV treatment (Control rAAV, n = 8; CaMK2N2 rAAV, 
n = 7). (i) CaMK2N2 overexpression did not affect CaMK2N1 mRNA levels (Control rAAV, n = 8; CaMK2N2 
rAAV, n = 7). Mean and S.E.M.; *P < 0.05; **P < 0.01; ***P < 0.001.
www.nature.com/scientificreports/
7Scientific RepoRts | 7: 4040  | DOI:10.1038/s41598-017-04355-8
T286 autophosphorylation and GluaA1 levels observed after CaMK2N1 knockdown might result in memory 
impairment due to blocking of memory destabilization. It is also possible that CaMK2N1 knockdown results 
in impairment of other steps of memory reconsolidation, however, more experiments are necessary to test this 
idea. Nevertheless, the clear separation of any retrieval-induced amnesic phenotype between a reconsolidation 
impairment and an increased memory extinction is still a matter of debate (see Trent, et al.21 and Almeida-Correa 
and Amaral22 for a more complete discussion on the subject).
Additionally, other molecular mechanisms could also be involved with the retrieval-dependent LTM impair-
ment due to CaMK2N1 knockdown. For example, CaMKII activity regulates protein degradation at synapses and 
LTM destabilization following retrieval21 and CaMKII interaction with F-actin has also been proposed to play 
an important structural role in LTM23. Enhanced adult neurogenesis in dentate gyrus has also been linked with 
forgetting23, but the short time course of our experiments makes it unlikely that CaMK2N1 regulates it.
Taken together, we establish for the first time a specific role for CaMK2N1 in learning and memory. CaMK2N1 
in dorsal hippocampus prevents fear LTM loss after retrieval by blocking T286 autophosphorylation of αCaMKII. 
It is possible that CaMK2N2 has a related function, since its expression is regulated after retrieval of a strong 
rather than weak LTM. Follow-up studies are needed to establish how CaMK2N1 and CaMK2N2 memory func-
tions relate to each other. Furthermore, more studies are necessary to address the effects of the retrieval-induced 
changes on CaMK2N1 and CaMK2N2 expression on βCaMKII function. It is also important to consider that the 
endogenous inhibitors of CaMKII have been show to also block CaMKII autophosphorylation at the T305 site13. 
A retrieval-dependent function for such CaMKII phosphorylation site has never been shown, nevertheless more 
experiments are important to approach this question. CaMK2N1 is also known to inhibit CaMKII binding to 
Cav2.1 calcium channels24. The relevance of such inhibition for memory maintenance is still unknown.
Treatment of post-traumatic stress disorder and drug addiction by facilitating memory extinction and/or 
impairing memory reconsolidation have been suggested and are a currently a major field of investigation25, 26. 
CaMK2N1 could be a possible molecular target for treating these diseases.
A relatively small increase of CaMK2N2 mRNA levels (~2.5 fold increase) in dorsal hippocampus did not affect 
contextual fear LTM. This result of CaMK2N2 overexpression confirms the independence of retrieval-induced 
LTM impairment from the CaMK2N2 mRNA increase observed concomitantly with CaMK2N1 knockdown. 
Higher levels of CaMK2N2 overexpression (50–80 fold increase) impaired LTM formation, but did not affect 
well-established contextual fear LTM. These results are in accordance with Buard, et al.4 reporting that CaMKII 
inhibition by tatCN21 administration impairs contextual fear memory formation but not LTM maintenance. 
Overall, the data presented here corroborate with the hypothesis that endogenous inhibition of CaMKII is nec-
essary for LTM maintenance after retrieval. Thus, CaMKII inhibition by CaMK2N2 overexpression or tatCN21 
treatment4 are not effective ways of studying CaMKII’s roles after LTM retrieval as they only increase the neces-
sary inhibition of CaMKII.
Mutation R495X in the FUS gene (also known as FUS-ΔNLS), an amyotrophic lateral sclerosis (ALS)/fronto-
temporal dementia (FTD) causing mutation27, has been shown, in vitro, to induce overexpression of CaMK2N228. 
We have observed that hippocampal CaMK2N2 overexpression impairs memory formation. ALS/FTD patients 
present cognitive impairments, with lower scores in tests of working memory, executive function, face recogni-
tion, and others29–31. It is possible that CaMK2N2 overexpression might be involved in the cognitive symptoms 
of ALS/FTD. Additionally, some forms of ALS/FTD includes the formation of inclusions with TAR DNA binding 
protein-43 (TDP-43) and RNA molecules in neurons32, 33. Wang, et al.34 has reported that mRNAs for αCaMKII 
are among the mRNAs trapped in TDP-43 inclusions. Also, loss of function in progranulin protein, an animal 
model that induces the appearance of TDP-43 inclusions, has been show to increase T286 autophosphorylation of 
αCaMKII35. Based on these evidences, more studies on the roles of CaMKII and CaMK2N2 in ALS’s progression 
and cognitive symptoms are important.
Methods
Animals. Male adult (10–12 week-old) C57BL/6J mice were group-housed in a 12-hour light-dark cycle with 
food and water ad libitum. For the experiments animals were divided between the treatments so that each cage 
would include animals from all the treatments. During the collection of behavioral and molecular data the exper-
imenter was blinded to the animal’s treatment. Experiments were repeated once or twice. All experiments were 
undertaken in accordance with local ethical reviewing at King’s College London, UK and in agreement with the 
UK Animals (Scientific Procedures) Act 1986.
Viral vectors. Three plasmids were generated in our laboratory, been those used for knocking down 
CaMK2N1, overexpressing CaMK2N2 or a control plasmid. Those plasmids were inserted in rAAV, serotype 
2/9 (Penn VectorCore, University of Pennsylvenia, USA), which were used as vectors for gene expression manip-
ulation in the dorsal hippocampus of mice. More details about the plasmids can be found in Supplementary 
Methods.
Stereotaxic surgery. Mice were subjected to stereotaxic surgery for bilateral injection of the rAAVs into the 
dorsal hippocampus. The coordinates for injection were anterior-posterior: +2.1 mm; medio-lateral: ±1.5 mm; 
dorso-ventral: −1.8 mm from bregma. The total volume of injection was 0.75 μl of viral vector solution at a rate of 
0.25 μl/min. More details on the surgery can be found on Supplementary Methods.
Contextual fear conditioning. Prior to behavioral protocol each animal was handled for 1 min-
ute for 5 days. For CFC the mouse was placed into the conditioning chamber (30.5 cm × 24.1 cm × 21.0 cm) 
(MedAssociates, VFC-008-LP), after 40 s one, three or five mild foot shocks (0.7 mA for 2 s) were given and after 
further 30 s the mouse was returned to its home cage (see, ref. 35). To test for contextual fear memory, the mouse 
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was returned to the same conditioning chamber and freezing behavior was scored for 2 s in 5 s intervals over a 
5 min period. Freezing was positively scored if no movement other than respiratory movements was observed. To 
control the shock and record animals’ behavior VFreeze software was used (MedAssociates). Scoring was done 
blind to treatment. In the first two experiments scoring was done twice by two different experimenters to test the 
precision of scoring.
RT-qPCR. In order to assess CaMK2N1 and CaMK2N2 mRNA expression levels RT-qPCR was used. 
RT-qPCR was executed following the procedures described in Lepicard, et al.11. Triplicates were used for each 
sample. A detailed description of the protocol and the primers used can be found in Supplementary Methods.
Western blot. Western blot technique was performed in order to quantify the levels of αCaMKII, GluA1 and 
αCaMKII T286 autophosphorylation. Crude synaptosome fractions were obtained following protocols previ-
ously published36–38. Quantification of bands was obtained after exposure in the linear range. Example images can 
be seen on Supplementary Fig. S7. A full description of the protocol used can be seen on Supplementary Methods.
Fluorescence microscopy. The rAAVs used had either ZsGreen or GFP as reporter genes. Expression of 
these fluorescent proteins after injection was assessed as a control for the surgery precision and viral transfection 
(Supplementary Fig. S1). A detailed explanation of the fluorescence microscopy procedure used is presented at 
Supplementary Methods.
Statistical analysis. Data were checked for normal distribution by Q-Q plot analysis, Kolmogorov-Smirnov 
and/or Shapiro-Wilk normality test. In case of non-normal distribution outliers were excluded from experiment 
as a normalization strategy. Outliers were defined as values that fall more than 1.5 times the interquartile range 
above the third quartile or below the first quartile. Animals treated with shCaMK2N1 rAAV were excluded from 
the experiment if the RT-qPCR analysis showed that the level of CaMK2N1 expression was an outlier in the 
group. This was considered to be an indication of treatment failure. The same principle was applied for animals 
treated with CaMK2N2-expressing rAAV but with RT-qPCR analysis of CaMK2N2 levels of expression. Animals 
which did not freeze in the memory test were excluded for the western blot analysis, since the aim was to look for 
molecular alterations related to memory changes. One-way ANOVA was used for analysis of dependent variables 
if the experiment had only one independent variable. In experiments with two independent variables, dependent 
variables were analyzed by two-way ANOVA, with repeated measures if necessary (for example when comparing 
behavioral results from first and second memory test). SNK test was used for post-hoc comparison as probing 
method for determining significant differences between different groups, once ANOVA revealed a significant 
difference.
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